Impact Of Clinical Pharmacist Intervention On Quality Of Life And Adherence To Drugs Using Sf-36 Score And Morisky Scale In Patients in Patients With Heart Failure In Azadi Teaching Hospital

Abstract

Background: Heart failure affecting a wide variety of population, causing high morbidity and mortality with high cost over a year, hospital based clinical pharmacist has an important role in management of patients with heart failure at level of drug monitoring, compliance, adherence to drugs and improving quality of life.
Aims of The Study: evaluation of the role of clinical pharmacist intervention in management, monitoring of drug therapy, compliance, adherence and improving quality of life in patients with Heart failure.
Methods: 100 patients involved in the study divided into two groups in this case-control comparison study 50 patients managed by MDT without participant of clinical pharmacist and the second 50 patients managed with MDT involving clinical pharmacist intervention using SF-36 score and Morisky scale.
Results: Results showed that there is a significant increase in EF% from (35.3±1.8) % to (43.3±1.9) % with a P-value of (0.001)
Conclusion: Clinical pharmacist intervention has a vital role in management of patients with Heart failure at a level of improving adherence, compliance, quality of life and as well as improving EF% of patients.